v3.26.1
STOCK AWARDS AND WARRANTS (Tables)
 3 Months Ended
Mar. 31, 2026
SCHEDULE OF STOCK OPTIONS

The following table summarizes all stock options as of March 31, 2026 (shares in thousands):

 

   2026 
   Shares   Price (1)   Term (2) 
             
Outstanding, at December 31, 2025   1,223   $6.83    7.6 
Granted   -    -      
Forfeited   (5)   -      
                
Outstanding, at March 31, 2026   1,218(3)  $6.12    7.4 
                
Exercisable, at March 31, 2026   174(4)   22.29    2.4 

 

(1) Represents the weighted average exercise price.
   
(2) Represents the weighted average remaining contractual term until the stock options expire.
   
(3) As of March 31, 2026, the aggregate intrinsic value of stock options outstanding was $0.
   
(4) As of March 31, 2026, the aggregate intrinsic value of exercisable stock options was $0.
SCHEDULE OF RSU GRANTED

The following table summarizes all RSU granted as of March 31, 2026 (shares in thousands):

 

   2026 
   Shares   Price (1)   Term (2) 
             
Outstanding, at December 31, 2025   90   $5.57    10 
Granted   -   $-      
Forfeited   -    -      
Exercised   -    -      
                
Outstanding, at March 31, 2026   90(3)  $5.57    10 
                
Exercisable, at March 31, 2026   -(4)   5.57    10 

 

(1) Represents the weighted average exercise price.
   
(2) Represents the weighted average remaining contractual term until the RSUs expire.
   
(3) As of March 31, 2026, the aggregate intrinsic value of stock options outstanding was $0.
   
(4) As of March 31, 2026, the aggregate intrinsic value of exercisable stock options was $0.
SCHEDULE OF WARRANT OUTSTANDING

Following is a summary of our warrants outstanding for the three months ended March 31, 2026 (shares in thousands):

 

   2026 
   Shares   Price (1)   Term (2) 
             
Outstanding, at December 31, 2025   11,782   $2.44    3.4 
Grants of warrants:               
Private placement   3,997           
Warrant inducement   4,103           
Exercised   (1,982)          
Outstanding, at March 31, 2026   17,900(3)  $2.36    3.4 
                
Exercisable, at March 31, 2026   17,847   $1.83    3.3 

 

(1) Represents the weighted average exercise price.
   
(2) Represents the weighted average remaining contractual term until the warrants expire.
   
(3) As of March 31, 2026, the aggregate intrinsic value of warrants outstanding was $0 million.
Warrant [Member]  
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTIONS USED IN THE FAIR VALUE

For the three months ended March 31, 2026, the valuation assumptions for warrants issued were estimated on the measurement date using the BSM option-pricing model with the following weighted-average input and assumptions:

 

   2026 
Measurement date closing price of Common Stock (1)  $1.68 
Contractual term (years) (2)   3.51 
Risk-free interest rate   4.0%
Volatility   148%
Dividend yield   -%

 

  (1) Weighted average grant price.
     
  (2) The valuation of warrants is based on the contractual term.